Intervention

Travoprost 0.004% ophthalmic solution

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

5 shown

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG PatientsNCT04461249 · 2019-06-01

Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®NCT01937299 · 2013-10-01

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®NCT01664039 · 2012-09-01

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)NCT01464424 · 2011-10-01

A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic SolutionNCT01485822 · 2004-07-01

Common conditions

Ocular Hypertension3 Glaucoma2 Open-Angle Glaucoma2 Open Angle Glaucoma1 Primary Open Angle Glaucoma1

Leading sponsors

Alcon Research4 Kasr El Aini Hospital1

Trial status mix

COMPLETED4

TERMINATED1

Phase mix

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.